Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions Psychedelics Investing
BioHarvest Sciences Inc. Projects 2022 Revenue to Grow 2.5X-3.5X to a Range of USD $5M-$7M Life Science Investing
Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine Pharmaceutical Investing
Numinus to Participate in Citi's Psychedelic Drug Call Series on February 2, 2022 Pharmaceutical Investing
Avricore Health CEO and Special Guests Join Radius Research for Investor Update Pharmaceutical Investing
 Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age Pharmaceutical Investing
Komo Plant Based Foods to be Available for Online Purchase Across the United States through GTFO It's Vegan Life Science Investing
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center
